JP2021504360A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021504360A5 JP2021504360A5 JP2020528323A JP2020528323A JP2021504360A5 JP 2021504360 A5 JP2021504360 A5 JP 2021504360A5 JP 2020528323 A JP2020528323 A JP 2020528323A JP 2020528323 A JP2020528323 A JP 2020528323A JP 2021504360 A5 JP2021504360 A5 JP 2021504360A5
- Authority
- JP
- Japan
- Prior art keywords
- inositol
- composition
- myo
- chiro
- weight ratio
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims 43
- 239000000203 mixture Substances 0.000 claims 24
- 229960000367 inositol Drugs 0.000 claims 23
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims 22
- CDAISMWEOUEBRE-LKPKBOIGSA-N 1D-chiro-inositol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O CDAISMWEOUEBRE-LKPKBOIGSA-N 0.000 claims 21
- 239000007901 soft capsule Substances 0.000 claims 10
- 201000010065 polycystic ovary syndrome Diseases 0.000 claims 6
- 239000003826 tablet Substances 0.000 claims 6
- 239000008187 granular material Substances 0.000 claims 4
- -1 sachets Substances 0.000 claims 4
- 239000007909 solid dosage form Substances 0.000 claims 4
- 108010010803 Gelatin Proteins 0.000 claims 3
- 229920000159 gelatin Polymers 0.000 claims 3
- 239000008273 gelatin Substances 0.000 claims 3
- 235000019322 gelatine Nutrition 0.000 claims 3
- 235000011852 gelatine desserts Nutrition 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 239000002775 capsule Substances 0.000 claims 2
- 239000007910 chewable tablet Substances 0.000 claims 2
- 239000007938 effervescent tablet Substances 0.000 claims 2
- 239000012729 immediate-release (IR) formulation Substances 0.000 claims 2
- 230000002611 ovarian Effects 0.000 claims 2
- 239000006187 pill Substances 0.000 claims 2
- 239000000843 powder Substances 0.000 claims 2
- 230000000638 stimulation Effects 0.000 claims 2
- 206010033266 Ovarian Hyperstimulation Syndrome Diseases 0.000 claims 1
- 230000032692 embryo implantation Effects 0.000 claims 1
- 230000002357 endometrial effect Effects 0.000 claims 1
- 239000002474 gonadorelin antagonist Substances 0.000 claims 1
- 238000002513 implantation Methods 0.000 claims 1
- 230000036512 infertility Effects 0.000 claims 1
- 208000000509 infertility Diseases 0.000 claims 1
- 231100000535 infertility Toxicity 0.000 claims 1
- 230000035935 pregnancy Effects 0.000 claims 1
- 210000004291 uterus Anatomy 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17382791 | 2017-11-23 | ||
| EP17382791.6 | 2017-11-23 | ||
| PCT/EP2018/060077 WO2019101368A1 (en) | 2017-11-23 | 2018-04-19 | Method for increasing embryo implantation rate in a female subject suffering polycystic ovary syndrome |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021504360A JP2021504360A (ja) | 2021-02-15 |
| JP2021504360A5 true JP2021504360A5 (https=) | 2021-05-27 |
| JP7257399B2 JP7257399B2 (ja) | 2023-04-13 |
Family
ID=60569854
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020528323A Active JP7257399B2 (ja) | 2017-11-23 | 2018-04-19 | 多嚢胞性卵巣症候群に罹患している女性患者における胚着床率を高める方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US11484540B2 (https=) |
| EP (1) | EP3713552A1 (https=) |
| JP (1) | JP7257399B2 (https=) |
| CN (1) | CN111655245B (https=) |
| AU (1) | AU2018373174B2 (https=) |
| BR (1) | BR112020010343A2 (https=) |
| CA (1) | CA3083301C (https=) |
| MA (1) | MA50784A (https=) |
| MX (1) | MX2020005223A (https=) |
| NZ (1) | NZ765637A (https=) |
| TW (1) | TWI842684B (https=) |
| WO (1) | WO2019101368A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2749783C1 (ru) * | 2020-12-11 | 2021-06-16 | Федеральное государственное автономное образовательное учреждение высшего образования "Российский национальный исследовательский медицинский университет имени Н.И. Пирогова" Министерства здравоохранения Российской Федерации (ФГАОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России) | Способ лечения синдрома поликистозных яичников, ассоциированного с метаболическим синдромом |
| CN114159402A (zh) * | 2021-12-21 | 2022-03-11 | 湖州展望天明药业有限公司 | 一种不透明植物胶囊及其制备方法 |
| EP4620480A1 (en) | 2022-11-16 | 2025-09-24 | Kansai Medical University Educational Corporation | Implantation facilitator, and screening system therefor |
| CN117017929B (zh) * | 2023-09-11 | 2024-11-08 | 山东奥克斯畜牧种业有限公司 | 一种用于提高采卵效果的组合物及其制备方法和应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2047686C (en) | 1989-03-08 | 2000-09-05 | Joseph Larner | Dietary supplement for insulin-resistant diabetics |
| US5563059A (en) | 1993-02-23 | 1996-10-08 | Genentech, Inc. | Use of human inhibin and human activin to increase the number of mature primate oocytes |
| US5906979A (en) * | 1998-01-27 | 1999-05-25 | Insmed Pharmaceuticals, Inc. | Compositions and methods for treating metabolic diseases characterized by hyperandrogenism and/or anovulation and/or infertility |
| US7105489B2 (en) * | 2002-01-22 | 2006-09-12 | Amylin Pharmaceuticals, Inc. | Methods and compositions for treating polycystic ovary syndrome |
| JP2006213684A (ja) | 2005-02-07 | 2006-08-17 | Hokko Chem Ind Co Ltd | インスリン抵抗性改善に用いられる組成物及び健康用食品 |
| ITRM20070341A1 (it) * | 2007-06-20 | 2008-12-21 | Lo Li Pharma Srl | Formulazione integrativa inofolic finalizzata al controllo dell'induzione dell'ovulazione in programmi di procreazione medicalmente assistita |
| EP2596132A4 (en) | 2010-07-23 | 2013-12-18 | Harvard College | METHOD FOR DETECTING SIGNS FOR ILLNESS OR SUFFERING IN BODY FLUIDS |
| ITMI20110445A1 (it) * | 2011-03-22 | 2012-09-23 | Lo Li Pharma Srl | Formulazione farmaceutica comprendente inositolo. |
| ITFI20110252A1 (it) * | 2011-11-22 | 2013-05-23 | Lo Li Pharma Srl | Composizione farmaceutica comprendente myo-inositolo e d-chiro-inositolo. |
| ITRM20130655A1 (it) * | 2013-11-26 | 2015-05-27 | Dicofarm Spa | Prodotto a base di una associazione di glucomannano ed inositolo |
| US9259410B2 (en) | 2014-04-08 | 2016-02-16 | Oculus Innovative Sciences, Inc. | Methods of treating polycystic ovarian syndrome using chlorogenic acid and inositol |
| IN2014MU01312A (https=) | 2014-04-09 | 2015-10-16 | Olive Healthcare | |
| ITUA20162575A1 (it) | 2016-04-13 | 2017-10-13 | S&R Farm S P A | Composizione farmaceutica o nutraceutica per l’uso nel trattamento della sindrome dell’ovaio policistico o di malattie o disturbi correlati ad essa |
| ITUA20163025A1 (it) * | 2016-04-29 | 2017-10-29 | Sochim Int S P A | Composizione per il trattamento della sindrome dell’ovaio policistico |
-
2018
- 2018-04-19 BR BR112020010343-8A patent/BR112020010343A2/pt not_active Application Discontinuation
- 2018-04-19 EP EP18718160.7A patent/EP3713552A1/en active Pending
- 2018-04-19 CN CN201880087590.2A patent/CN111655245B/zh active Active
- 2018-04-19 NZ NZ765637A patent/NZ765637A/en unknown
- 2018-04-19 CA CA3083301A patent/CA3083301C/en active Active
- 2018-04-19 MA MA050784A patent/MA50784A/fr unknown
- 2018-04-19 JP JP2020528323A patent/JP7257399B2/ja active Active
- 2018-04-19 US US16/766,062 patent/US11484540B2/en active Active
- 2018-04-19 MX MX2020005223A patent/MX2020005223A/es unknown
- 2018-04-19 WO PCT/EP2018/060077 patent/WO2019101368A1/en not_active Ceased
- 2018-04-19 AU AU2018373174A patent/AU2018373174B2/en active Active
- 2018-11-16 TW TW107140812A patent/TWI842684B/zh active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021504360A5 (https=) | ||
| EP0749308B1 (en) | Film coated tablet of paracetamol and domperidone | |
| JP2005510485A5 (https=) | ||
| EP3130334B1 (en) | Controlled-release solid preparation with partial coating | |
| NO341027B1 (no) | Tablett med høyt medikamentinnhold og fremgangsmåte for fremstilling derav | |
| EP3041511A2 (en) | Compositions of eltrombopag | |
| JPH08502980A (ja) | 薬剤配送装置 | |
| JPH03500288A (ja) | 徐放性ニフェジピン製剤 | |
| JP6476331B2 (ja) | イソニアジドの顆粒およびリファペンチンの顆粒を含む分散性錠剤の形態の抗結核性の安定な医薬組成物ならびにその製造方法 | |
| JP2015120758A5 (https=) | ||
| CN101120930B (zh) | 一种奥美拉唑组合物及其制备方法 | |
| CN105267172A (zh) | 简易制备结肠炎和克罗恩病用高载药量缓释制剂的方法 | |
| JP2011507853A5 (https=) | ||
| JP2023510965A5 (https=) | ||
| JP2022508236A5 (https=) | ||
| FI3886857T3 (fi) | Montelukasti erosiivisen käden nivelrikon hoitoon | |
| Murthy et al. | Formulation, characterization and drug release kinetics of floating drug delivery systems | |
| WO2016203018A1 (en) | Pharmaceutical compositions of prasugrel hydrobromide | |
| RU2188018C2 (ru) | Композиционный состав антибактериального лекарственного средства | |
| TW201716063A (zh) | 維生素c和鋅之穩定組合物錠劑 | |
| CN106924270B (zh) | 一种含有奥利司他的具有减肥功能的药物组合物 | |
| US20160045442A1 (en) | Stable pharmaceutical compositions of mesalamine | |
| HK1207588A1 (en) | Use and application regimen of a pharmaceutical composition containing levonorgestrel and a cox inhibitor for on-demand contraception | |
| CN104758180A (zh) | 一种复方制剂胶囊的二次填充方法 | |
| JP2018530538A5 (https=) |